Home › Funds › ADAR1 Capital Management, LLC › IMVT

ADAR1 Capital Management, LLC position in IMVT

IMMUNOVANT INC COM · Health Care

ADAR1 Capital Management, LLC reported holding 2,330,716 shares of IMVT (IMMUNOVANT INC COM) in its Q2 2026 13F filing — a position valued at US$89.8M, representing 4.97% of its reported portfolio and ranking #3 among its reported holdings. ADAR1 Capital Management, LLC has disclosed IMVT holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)2.33M sh
Reported value held$89.80M
Portfolio Weight4.97%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ADAR1 Capital Management, LLC's IMVT position evolved

ADAR1 Capital Management, LLC first disclosed a stake in IMVT in Q4 2023 at 134,125 shares (US$5.7M). The position peaked in Q2 2026 at 2,330,716 shares, worth US$89.8M. Across 11 filings, ADAR1 Capital Management, LLC increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,330,716 shares valued at US$89.8M — a reduction of -348,294 shares quarter over quarter.. Notable position changes include a 684% increase in Q2 2024 (shares rose 8% over the following quarter), a 7620% increase in Q4 2024 (shares fell 31% over the following quarter), a 319% increase in Q3 2025 (shares rose 58% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 134.12K $5.65M New
Q1 2024 60.76K $1.96M Reduce
Q2 2024 476.54K $12.58M Add
Q3 2024 10.20K $290.80K Reduce
Q4 2024 787.48K $19.51M Add
Q1 2025 968.87K $16.56M Add
Q2 2025 535.07K $8.56M Reduce
Q3 2025 2.24M $36.14M Add
Q4 2025 2.48M $63.07M Add
Q1 2026 2.68M $66.55M Add
Q2 2026 2.33M $89.80M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMVT and 13F data

IMVT (IMMUNOVANT INC COM) is a Health Care company. 39 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$359.9M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMVT

All IMVT fund holders →

FAQ

How long has ADAR1 Capital Management, LLC held IMVT?

ADAR1 Capital Management, LLC has disclosed IMVT holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is ADAR1 Capital Management, LLC's current position in IMVT?

As of Q2 2026, ADAR1 Capital Management, LLC holds 2.33M shares of IMVT (IMMUNOVANT INC COM), valued at $89.80M, representing 4.97% of its reported portfolio and ranking #3.

Has ADAR1 Capital Management, LLC been buying or selling IMVT?

In the latest 13F filing (Q2 2026), ADAR1 Capital Management, LLC reduced its position in IMVT. The position peaked in Q2 2026 at 2.33M shares.

Which other funds hold IMVT?

Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.